ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1358	National Cancer Institute	Html	en	Gastrointestinal Complications (PDQ®)–Health Professional Version	Expert-reviewed information summary about constipation, impaction, bowel obstruction, and diarrhea as complications of cancer or its treatment. The management of these problems is discussed.	complete bowel obstruction 0.653864 stool 0.625324 gastrointestinal tract 0.642496 Oncol Nurs Forum 0.609323 cancer-related diarrhea 0.733825 refractory diarrhea 0.683452 diarrhea management 0.729396 total bowel rest 0.605453 diarrhea events 0.682702 bone marrow transplantation 0.599048 PUBMED Abstract 0.628255 octreotide acetate 0.600127 bowel lumen 0.596911 abdominal pain 0.618725 progressive bowel obstruction 0.651874 normal bowel function 0.623449 bowel obstruction 0.807553 Support Care Cancer 0.590223 acute diarrhea 0.731833 traveler’s diarrhea 0.692746 regimen-related diarrhea 0.681582 small bowel 0.642547 somatostatin analog octreotide 0.636325 depot octreotide 0.600959	chemotherapy-induced diarrhea 0.813859 malignant bowel obstruction 0.739577 cancer care 0.622581 cancer treatment-induced diarrhea 0.733195 severe diarrhea 0.723383 irritable bowel syndrome 0.602845 patients 0.752157 Clin Oncol 0.637052 cancer patients 0.616135 radiation-induced diarrhea 0.788656 neurogenic bowel dysfunction 0.61585 diarrhea 0.944656 inflammatory bowel disease 0.603068 bone marrow 0.600992 gastrostomy tube 0.601159 Nutr Clin Pract 0.61137 pelvic radiation-induced diarrhea 0.726181 octreotide 0.694845 extraluminal bowel lesions 0.625405 Delayed diarrhea 0.692341 fecal impaction 0.682249 et al. 0.624888 Subcutaneous octreotide 0.602593	CLICK HERE
1604	National Cancer Institute	Html	en	Bladder and Other Urothelial Cancers Screening (PDQ®)–Patient Version	Expert-reviewed information summary about tests used to detect or screen for bladder cancer.	red blood cells 0.494369 cancer treatment 0.489394 bladder cancers 0.541229 urine 0.494083 ongoing clinical trials 0.492966 bladder urothelium 0.575205 following PDQ summaries 0.556519 Transitional cell carcinoma 0.483769 PDQ cancer information 0.750577 cancer increases 0.491939 false-negative test result 0.489029 bladder cancer 0.812624 clinical trials 0.684635 test result 0.523443 special test strip 0.489962 cancer information summary 0.626401 clinical trial 0.502183 breast cancer prevention 0.514992 false-positive test result 0.488801 cancer patients 0.484495 latest published information 0.497666 NCI’s PDQ 0.51339 cancer symptoms 0.50531 NCI PDQ cancer 0.589485	tests 0.518118 Squamous cell carcinoma 0.486084 PDQ Screening 0.538371 screening tests 0.491835 Cancer Information Service 0.53331 urothelial cancers 0.536876 PDQ Bladder 0.571685 Prevention Editorial Board 0.549647 treatment clinical trials 0.491831 National Cancer Institute 0.634201 PDQ documents 0.50321 cell carcinoma 0.486793 new treatment 0.498073 Cancer screening trials 0.570719 Cancer Care page 0.519283 PDQ database 0.508182 risk factor 0.512484 PDQ summary 0.54439 cells 0.496479 cancer information summaries 0.541898 comprehensive cancer information 0.541535 renal pelvis 0.488981 cancer 0.961972 Urothelial Cancers Screening 0.519534	CLICK HERE
1723	National Cancer Institute	Html	en	Cell Phones and Cancer Risk	A fact sheet that outlines the available evidence regarding use of cellular/mobile telephones and cancer risk.	study participants 0.44259 Self-reported cell phone 0.407518 past cell phone 0.400866 cell phone calls 0.471967 interphone study 0.417191 cell phone subscribers 0.456865 brain glucose metabolism 0.405692 brain tumors 0.529155 case-control study 0.507596 typical cell phone 0.408953 radiofrequency electromagnetic radiation 0.493663 radiofrequency energy exposure 0.501417 cell phone service 0.411175 radiofrequency energy 0.823507 brain cancer 0.549627 cell phone exposure 0.408273 mobile phone radiation 0.402738 cell phone base 0.419397 mobile phone 0.45428 specific absorption rate 0.399693 GSM mobile phone 0.393442 glucose metabolism 0.4091 Brain cancer incidence 0.408493 brain tumor incidence 0.393633 cell phone user 0.438311	study 0.591826 cohort study 0.434065 United States 0.44975 epidemiologic studies 0.488267 brain tumor risk 0.390841 cell phone 0.960278 cell phone technology 0.436997 National Cancer Institute 0.439672 long-term cell phone 0.404741 cell phones 0.77677 international case-control study 0.404344 prospective cohort study 0.39373 brain tumor 0.434845 brain cancer risk 0.419878 brain 0.559028 regular cell phone 0.406823 non-ionizing radiation 0.395758 cell phone radiofrequency 0.472899 cell phone users 0.536299 cell phone records 0.414439 et al 0.586681 cancer risk 0.424868 cancer 0.54982 risk 0.454009	CLICK HERE
1779	National Cancer Institute	Html	es	Depresión (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del diagnóstico, evaluación y tratamiento de la depresión en adultos y niños que padecen de cáncer.	Cancer Inst Monogr 0.432628 depression among 0.428544 depression screening tools 0.450792 adjustment disorders 0.418823 Breitbart W 0.449695 psychiatric complications 0.429171 Massie MJ 0.417743 Manual diagnóstico 0.431383 Sin embargo 0.431066 early depressive symptoms 0.421567 Symptom Management 0.420302 women with 0.486443 Lloyd-Williams M 0.434521 major depression 0.457401 cancer care 0.484374 depressive symptom 0.530327 cancer patients 0.968062 managing depression 0.427561 Natl Cancer Inst 0.494477 mental disorders 0.453242 Chochinov HM 0.433278 patients with 0.642851 with cancer 0.624444 Pain Symptom Manage 0.512784 Med Lett Drugs 0.432345	Akechi T 0.426152 patients treated with 0.419464 women with breast 0.476007 American Psychiatric Association 0.511308 Care Cancer 0.429533 hospital anxiety 0.515664 cáncer experimentarán 0.417323 palliative care 0.465506 with newly 0.422401 Assessing depression 0.439637 Cancer survival probability 0.429646 Distress Thermometer 0.454338 Patient With Cancer 0.438222 newly diagnosed breast 0.416572 Clin Oncol 0.523008 Self-Rating Depression Scale 0.427421 depresión subclínica 0.429498 depression scale 0.646561 Ravaud A 0.427826 Which depression screening 0.428471 Mood Evaluation Questionnaire 0.417145 escala visual analógica 0.428616 Lett Drugs Ther 0.430932 Holland JC 0.47612	CLICK HERE
1829	National Cancer Institute	Html	es	Tratamiento de la leucemia mieloide aguda en adultos (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento de la leucemia mieloide aguda en adultos.	displasia multilinaje 0.472943 panmielosis aguda 0.415823 clasificación fab m3 0.409639 clasificación fab m4 0.409698 Sarcoma mieloide 0.405446 clasificación fab m1 0.409959 clasificación fab 0.532219 clasificación fab m2 0.426424 clasificación fab m0 0.410206 FLT3 internal tandem 0.405506 FAB M7).Leucemia mieloide 0.407876 leucemia mielomonocítica aguda 0.44636 linaje mixto aguda 0.409505 Leucemia basofílica aguda 0.420705 adults with 0.404981 clasificaciones fab 0.428261 PDQ Fatiga 0.40748 gránulos azurófilos 0.405489 Cooperative Oncology Group 0.40522 Medical Research Council 0.409556 características.Leucemia mieloide aguda 0.413751 leucemia promielocítica aguda 0.512621 leucemia mielógena aguda 0.421257 leucemia linfocítica aguda 0.421928 leucemia aguda 0.446208	leucemia linfoblástica aguda 0.418991 síndromes mielodisplásicos 0.434423 internal tandem duplication 0.404884 Southwest Oncology Group 0.404924 precursores eritroides 0.414014 acute myeloid leukemia 0.447161 leucemia monoblástica aguda 0.532852 La leucemia 0.450537 diferenciación mieloide 0.40824 leucemia megacarioblástica aguda 0.50072 leucemia monocítica aguda 0.603201 transcripción mieloide 0.405494 clasificaciones fab m5a 0.408093 PDQ Tratamiento 0.410351 leucemia megacariocítica aguda 0.417046 leucemia mieloblástica aguda 0.541661 leucemia eritroide 0.432974 características clínicas 0.409864 leucemia mieloide aguda 0.973753 Southwest Oncology 0.405587 Oncology Group 0.408557 importante componente mieloide 0.404879 clasificaciones fab m6a 0.412966 tratamiento.Leucemia mieloide aguda 0.414418	CLICK HERE
1859	National Cancer Institute	Html	es	Tratamiento del cáncer de hipofaringe (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del cáncer de hipofaringe.	Neck Cancer Cooperative 0.13741 pharyngeal cancers 0.150792 Pfister DG 0.13468 pyriform sinus treated 0.135606 Cancer Res 0.206838 Radiat Oncol Biol 0.237454 DeVita VT Jr 0.131516 pyriform sinus 0.18629 Natl Cancer Inst 0.207961 radiation therapy 0.254373 Head Neck Surg 0.418544 carcinoma treated with 0.123784 squamous carcinoma 0.207808 with surgery 0.155955 Mendenhall WM 0.309662 Head Neck 0.426668 estadio iv 0.131056 neck squamous 0.149286 Parsons JT 0.126343 radioterapia preoperatoria versus 0.132896 sinus treated with 0.147408 treated with surgery 0.145993 radioterapia posoperatoria 0.168742 Oral Oncol 0.128712 Hendrickson FR 0.131539	treatment based 0.121981 Otolaryngol Head Neck 0.206433 hypopharyngeal carcinomas 0.157978 radiotherapy with 0.12894 with poor prognosis 0.124956 hypopharyngeal squamous 0.152628 Spindle cell carcinoma 0.12283 Clin Oncol 0.138573 combined with neck 0.126143 Oncol Biol Phys 0.243047 combining radiotherapy with 0.126277 estadio iii 0.184936 radiotherapy with surgery 0.128843 Treat Options Oncol 0.123145 radioterapia adyuvante posoperatoria 0.177283 European Organization 0.12179 neck cancer 0.973991 undifferentiated carcinomas 0.126856 quimioterapia neoadyuvante 0.630349 locally advanced 0.131399 Hansen O 0.125257 induction chemotherapy 0.134893 neck carcinoma 0.172184 squamous cell carcinoma 0.867141	CLICK HERE
1887	National Cancer Institute	Html	es	Tratamiento del carcinoma de células de Merkel (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del carcinoma de células de Merkel.	Cutan Pathol 0.403221 skin cancer 0.402076 critical review with 0.401107 cell carcinoma showing 0.404318 review with guidelines 0.401112 Australian Merkel cell 0.404544 Distinct merkel cell 0.404503 Am Acad Dermatol 0.404485 cell polyomavirus dna 0.402185 Curr Opin Oncol 0.401201 Cell Carcinoma Information 0.404476 7th ed 0.401399 Rockville Merkel Cell 0.404613 ganglios linfáticos centinela 0.405335 SEER Program 0.402412 cell carcinoma tumors 0.407605 Coit DG 0.402335 into merkel cell 0.405013 Seattle Cancer Care 0.401199 Cancer Care Alliance 0.401228 Natl Cancer Inst 0.40149 Merkel tumours 0.402858 patients with merkel 0.422467 with cutaneous merkel-cell 0.401294 Arch Dermatol 0.401934	cutaneous merkel-cell carcinoma 0.404932 with merkel cell 0.435163 Invest Dermatol 0.401806 neuroendocrine-merkel cell carcinoma 0.404323 Cancer Staging Manual 0.402011 patients from 0.401403 Surg Oncol 0.411261 Nghiem P 0.404669 New York 0.401702 merkel cell carcinoma 0.998942 specimens from patients 0.401221 Clin Oncol 0.41408 Dermatol Surg 0.40166 CCM recién 0.401912 Carcinoma Group 0.402481 cell carcinoma demographics 0.418051 primary merkel 0.405524 Trabecular carcinoma 0.402756 American Joint Committee 0.401365 merkel cell polyomavirus 0.432273 cell carcinoma after 0.40431 cell polyomavirus infection 0.402124 merkel-cell carcinoma 0.40673 from patients with 0.402629	CLICK HERE
1897	National Cancer Institute	Html	es	Tratamiento del linfoma no Hodgkin en adultos (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del linfoma no Hodgkin en adultos.	linfáticos afectados.ampliar linfoma 0.556638 TLAM extragástrico empieza 0.429482 causa signos 0.417964 siguientes aspectos 0.411989 anticuerpos monoclonales tipo 0.445884 humano tipo 0.426884 estadio s 0.418117 células t 0.850788 líquido cefalorraquídeo 0.542154 linfocitos b 0.562716 presente sumario 0.415398 Leucemia mieloide aguda 0.412625 células cn /T 0.476942 Non-Hodgkin Lymphoma 0.418323 linfocitos t 0.430669 Campylobacter jejuni 0.413748 ósea fabrica glóbulos 0.447079 ciclina d1 0.412001 principales tipos 0.445871 espacios huecos 0.457401 células cn 0.541653 estadio iiie+s 0.436889 células madre 0.466311 adultos jóvenes 0.471716 proteína tipo cinasa 0.438832	estadio iv 0.435605 sudores nocturnos 0.53266 leucemia linfoblástica aguda 0.472861 siguientes tipos 0.440813 proteína alk 0.412629 abdomen).ampliar linfoma 0.528931 enlace drugs approved 0.432641 efectos tardíos 0.529479 estadio ie 0.461288 Burkitt esporádico 0.418236 anticuerpos igm 0.417141 estadio iie 0.436552 líquido incoloro 0.417873 estadio iiie 0.489124 sistema nervioso central 0.470481 linfoma tlam 0.967052 tejido linfoide 0.471693 siguientes partes 0.417527 granulomatosis linfomatoide 0.47171 estadio iiis 0.721469 almacena glóbulos 0.423547 células b 0.535619 siguientes pruebas 0.426588 siguientes sumarios 0.417246	CLICK HERE
1903	National Cancer Institute	Html	es	Tratamiento del linfoma no Hodgkin infantil (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del linfoma no Hodgkin infantil.	siguientes procedimientos 0.533869 posibles efectos tardíos 0.429839 células madre 0.925937 posibles factores 0.42224 adultos jóvenes 0.471015 estadio iv 0.456127 Burkitt recién 0.429453 sistema linfático.Para 0.433317 faja ajustadora 0.424807 gen alk 0.453637 leucemia linfoblástica aguda 0.499911 estadio ii 0.457571 siguientes especialistas 0.421884 siguientes tipos 0.435023 rayos x 0.42189 después.ampliar ecografía 0.422758 enlace drugs approved 0.552427 niño ayuda 0.422955 Sudores nocturnos 0.425131 ondas sonoras 0.421599 células t 0.997508 efectos tardíos 0.61792 PDQ Efectos tardíos 0.432774 líquido cefalorraquídeo 0.752047	sección linfoma 0.486518 Linfoma folicular tipo 0.701733 linfocitos b 0.461134 La terapia 0.636115 encontrarlo.ampliar exploración 0.423664 determinados cambios 0.538253 PDQ Tratamiento 0.508964 líquido incoloro 0.436562 explorador tep 0.424899 siguientes factores 0.424861 sistema nervioso central 0.543338 proteína llamada cinasa 0.449366 mayores probabilidades 0.423685 Non-Hodgkin Lymphoma 0.486305 estadio i 0.458742 tipo paniculitis 0.446711 Estados Unidos 0.425103 estadio iii 0.456847 tejido linfoide 0.449965 ósea fabrica glóbulos 0.477114 almacena glóbulos 0.436048 células b 0.553761 Hodgkin infantil recidivante 0.525837	CLICK HERE
1922	National Cancer Institute	Html	es	Tratamiento del cáncer de próstata (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del cáncer de próstata.	paciente presente síntomas 0.437409 siguientes procedimientos 0.452293 dé tratamiento 0.439746 estadio iv 0.493208 hiperplasia prostática benigna 0.97293 ecografía transrectal 0.704162 pequeña cantidad 0.628387 peores efectos 0.412864 estadio ii 0.558135 siguientes tipos 0.419876 tumor dosis 0.421814 rayos x 0.418531 sistema urinario masculino 0.436824 ondas sonoras 0.422219 principal fuente 0.412408 características sexuales masculinas 0.423477 enlace medicamentos 0.465713 National Cancer Institute 0.412027 sustancia radiactiva llamada 0.426571 biopsia.ampliar ecografía 0.431707 Instituto Nacional 0.421293 estadios iia 0.418459	hormonas masculinas 0.458793 PDQ Tratamiento 0.424516 hormonas sexuales masculinas 0.442195 estadio iia 0.431816 siguientes problemas 0.426176 presente sección 0.409743 tejidos cercanos.A veces 0.421604 Physician Data Query 0.443132 posibles problemas 0.411863 Estados Unidos 0.4216 estadio iii 0.498677 linfadenectomía pélvica 0.487486 prostatectomía radical.ampliar resección 0.439705 aparato reproductor masculino 0.440962 siguientes sustancias 0.416831 hipertrofia prostática benigna 0.438255 alta intensidad 0.548873 prostatectomía retropúbica 0.464416 Ganas repentinas 0.423669 próstata solas 0.515159 siguientes pruebas 0.46951 siguientes estadios 0.460134	CLICK HERE